Pathologic complete response with radiation and vismodegib in a patient with advanced basal cell carcinoma: A case report.
Mol Clin Oncol
; 14(3): 46, 2021 Mar.
Article
en En
| MEDLINE
| ID: mdl-33575030
ABSTRACT
In locally advanced basal cell carcinoma (BCC) patients who are not surgical candidates and where radiation therapy (RT) alone would offer lower control rates, the combination of vismodegib and RT delivered concurrently may potentially improve outcomes compared to single modality treatment. The current study presents a case of very advanced, multifocal BCC who received concurrent vismodegib and RT. The patient initially came in with four large primary areas of disease including the left preauriculum, right shoulder, chest wall and right lateral ankle. All sites achieved a clinical complete response, with a pathologic complete response at the right shoulder. The ankle lesion did not require RT and continues to have a clinical complete response. The findings from our case report support several other cases with similar efficacy when vismodegib and RT are combined.
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Idioma:
En
Revista:
Mol Clin Oncol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Estados Unidos